Document Detail


Experimental Cell Research Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping Beauty transposon mediated gene transfer.
MedLine Citation:
PMID:  22846649     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Induced pluripotent stem (iPS) cell technology involves reprogramming somatic cells to a pluripotent state. The original technology used to produce these cells requires viral gene transduction and results in the permanent integration of exogenous genes into the genome. This can lead to the development of abnormalities in the derived iPS cells. Here, we report that non-viral transfection of a Sleeping Beauty (SB) transposon containing the coding sequences Oct3/4 (Pouf1), Sox-2, Klf-4 and c-Myc (OSKM) linked with 2A peptides, can reprogram mouse fibroblasts. We have established reprogrammed mouse cell lines from three different genetic backgrounds: (1) ICR - outbred, (2) C57BL/6 - inbred and (3) F1-hybrid (C57BL/6 x DBA/2J), with parallel robust expression of all exogenous (Oct3/4, Sox-2, Klf-4, and c-Myc) and endogenous (e.g. Oct3/4 and Nanog) pluripotency genes. The iPS cell lines exhibited characteristics typical for undifferentiated embryonic stem (ES) cell lines: ES cell-like morphology, alkaline phosphatase (ALP) positivity and gene expression pattern (shown by reverse transcription PCR, and immunofluorescence of ES cell markers - e.g. Oct3/4, SSEA1, Nanog). Furthermore, cells were able to form embryoid bodies (EBs), to beat rhythmically, and express cardiac (assayed by immunofluorescence, e.g. cardiac Troponin T, desmin) and neuronal (assayed by immunofluorescence e.g. nestin, Tuj1) markers. The in vitro differentiation potential was found to be the highest in the ICR-derived iPS lines (ICR-iPS). Interestingly, the ICR-iPS lines had even higher differentiation potential than the ICR-ES cell lines: the rate of EBs forming rhythmically beating cardiomyocytes was 4% in ICR-ES and 79% in ICR-iPS cells, respectively. In vivo, the ICR and F1 hybrid iPS cells formed chimeras and one of the iPS cells from the F1 hybrid background transmitted to the germline. Our results suggest that iPS technology may be useful for generating pluripotent stem cells from genetic backgrounds of which good quality ES cell generation is difficult. These studies provide insights into viral-free iPS technology and may contribute towards defining future cell-based therapies, drug-screening methods and production of transgenic animals using genetically modified iPS cells.
Authors:
Suchitra Muenthaisong; Olga Ujhelly; Zsuzsanna Polgar; Eszter Varga; Zoltan Ivics; Melinda K Pirity; Andras Dinnyes
Related Documents :
6952709 - Discrimination between primary pleural and primary peritoneal mesotheliomas by morphome...
20014549 - Diagnostic utility of moc-31, hbme-1 and moc-31 mrna in distinguishing between carcinom...
570299 - Scanning electron microscopy of exfoliated malignant and non-malignant human urothelial...
21556569 - Antagonists of bombesin/gastrin-releasing peptide inhibit growth of jar human choriocar...
20125039 - Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma fro...
3675799 - Relation of quantitative features of visually normal intermediate cells in cervical int...
1722349 - Studies of isolated parietal and enterochromaffin-like cells from the rat.
18835599 - Tunneling nanotubes (tnt) are induced by hiv-infection of macrophages: a potential mech...
6132489 - Endocrine cells in the prostate gland, urothelium and brenner tumors. immunohistologica...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-27
Journal Detail:
Title:  Experimental cell research     Volume:  -     ISSN:  1090-2422     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0373226     Medline TA:  Exp Cell Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Molecular Animal Biotechnology Laboratory, Szent István University, Gödöllö, 2100 Hungary; BioTalentum Ltd, Gödöllö, 2100 Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Retrieving oocytes from small non-stimulated follicles in polycystic ovary syndrome (PCOS): in vitr...
Next Document:  Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania.